[Neuroleptics].
D000014:Abnormalities, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002090:Butyrophenones / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008431:Maternal-Fetal Exchange; D010546:Perphenazine / Q000009:adverse effects; D011247:Pregnancy; D011346:Prochlorperazine / Q000009:adverse effects; D013723:Teratogens; D013881:Thioridazine / Q000009:adverse effects; D014273:Triflupromazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D002090:Butyrophenones; D013723:Teratogens; D010546:Perphenazine; D006220:Haloperidol; D013881:Thioridazine; D014273:Triflupromazine; D005476:Fluphenazine; D002746:Chlorpromazine; D011346:Prochlorperazine
Neuroleptika